1.
The effect of systemic erythropoietin and oral prednisolone on recent-onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial.
Nikkhah Homayoun, Golalipour Mahya, Doozandeh Azadeh, Pakravan Mohammad, Yaseri Mehdi, Esfandiari Hamed
Graefes Arch Clin Exp OphthalmolJun 202014 citationsRandomized Controlled Trial
This study found systemic erythropoietin improved visual acuity and optic nerve structure in recent-onset NAION patients, suggesting a potential new therapy for this vision-threatening condition.